Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service

P. Araos; Esperanza Vergara-Moragues; Francisco González-Saiz; María Pedraz; Nuria García-Marchena; Pablo Romero-Sanchiz; Juan Jesus Ruiz; Rafael Campos-Cloute; Antonia Serrano; Francisco Javier Pavón; Marta Torrens; Fernando Rodriguez De Fonseca

doi:10.1080/02791072.2017.1342151

Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service

P. Araos, Esperanza Vergara-Moragues, Francisco González-Saiz, María Pedraz, Nuria García-Marchena, Pablo Romero-Sanchiz, Juan Jesus Ruiz, Rafael Campos-Cloute, Antonia Serrano, Francisco Javier Pavón, Marta Torrens, Fernando Rodriguez De Fonseca

School of Psychology

Research output: Contribution to journal › Article › peer-review

Abstract

Cocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.

Original language	English
Pages (from-to)	306-315
Number of pages	10
Journal	Journal of Psychoactive Drugs
Volume	49
Issue number	4
DOIs	https://doi.org/10.1080/02791072.2017.1342151
Publication status	Published - 6 Jul 2017

Keywords

Ambulatory treatment centers
cocaine use disorder
psychiatric comorbidity
substance use disorder
therapeutic communities

Access to Document

10.1080/02791072.2017.1342151

Cite this

Araos, P., Vergara-Moragues, E., González-Saiz, F., Pedraz, M., García-Marchena, N., Romero-Sanchiz, P., Ruiz, J. J., Campos-Cloute, R., Serrano, A., Pavón, F. J., Torrens, M., & Rodriguez De Fonseca, F. (2017). Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service. Journal of Psychoactive Drugs, 49(4), 306-315. https://doi.org/10.1080/02791072.2017.1342151

@article{fbe85f3db6804f748a543938a600ce5e,

title = "Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service",

abstract = "Cocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.",

keywords = "Ambulatory treatment centers, cocaine use disorder, psychiatric comorbidity, substance use disorder, therapeutic communities",

author = "P. Araos and Esperanza Vergara-Moragues and Francisco Gonz{\'a}lez-Saiz and Mar{\'i}a Pedraz and Nuria Garc{\'i}a-Marchena and Pablo Romero-Sanchiz and Ruiz, {Juan Jesus} and Rafael Campos-Cloute and Antonia Serrano and Pav{\'o}n, {Francisco Javier} and Marta Torrens and {Rodriguez De Fonseca}, Fernando",

year = "2017",

month = jul,

day = "6",

doi = "10.1080/02791072.2017.1342151",

language = "English",

volume = "49",

pages = "306--315",

journal = "Journal of Psychoactive Drugs",

issn = "0279-1072",

publisher = "Routledge: Taylor & Francis Group",

number = "4",

}

Araos, P, Vergara-Moragues, E, González-Saiz, F, Pedraz, M, García-Marchena, N, Romero-Sanchiz, P, Ruiz, JJ, Campos-Cloute, R, Serrano, A, Pavón, FJ, Torrens, M & Rodriguez De Fonseca, F 2017, 'Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service', Journal of Psychoactive Drugs, vol. 49, no. 4, pp. 306-315. https://doi.org/10.1080/02791072.2017.1342151

Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service. / Araos, P.; Vergara-Moragues, Esperanza; González-Saiz, Francisco et al.
In: Journal of Psychoactive Drugs, Vol. 49, No. 4, 06.07.2017, p. 306-315.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service

AU - Araos, P.

AU - Vergara-Moragues, Esperanza

AU - González-Saiz, Francisco

AU - Pedraz, María

AU - García-Marchena, Nuria

AU - Romero-Sanchiz, Pablo

AU - Ruiz, Juan Jesus

AU - Campos-Cloute, Rafael

AU - Serrano, Antonia

AU - Pavón, Francisco Javier

AU - Torrens, Marta

AU - Rodriguez De Fonseca, Fernando

PY - 2017/7/6

Y1 - 2017/7/6

N2 - Cocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.

AB - Cocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.

KW - Ambulatory treatment centers

KW - cocaine use disorder

KW - psychiatric comorbidity

KW - substance use disorder

KW - therapeutic communities

U2 - 10.1080/02791072.2017.1342151

DO - 10.1080/02791072.2017.1342151

M3 - Article

SN - 0279-1072

VL - 49

SP - 306

EP - 315

JO - Journal of Psychoactive Drugs

JF - Journal of Psychoactive Drugs

IS - 4

ER -